Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) has shared an announcement.
Syntara Limited has announced the cessation of 452,430 performance rights due to the lapse of conditional rights that were not met or became incapable of being satisfied. This cessation could impact the company’s capital structure and may have implications for stakeholders, reflecting on the company’s ability to meet certain performance conditions.
More about Pharmaxis Ltd
YTD Price Performance: -7.50%
Average Trading Volume: 2,817,058
Technical Sentiment Signal: Hold
Current Market Cap: A$120.1M
See more insights into SNT stock on TipRanks’ Stock Analysis page.